#	Pagina
attuale pagina	/open-h2020/projects/226453/index.html
-1	/open-h2020/per-topic/akshay/list/index.html
-2	/open-h2020/per-topic/biosphere/list/index.html
-3	/open-h2020/per-topic/mesejo/list/index.html
-4	/open-consip/fornitori/2021/profilo-03450810365/index.html
-5	/open-carburanti/provincia-tr/index.html/47278/45183/54708/55171/34580/15630/19542/24432/index.html
-6	/open-carburanti/provincia-tr/index.html/15151/6616/52225/9973/24627/13099/52794/54708/index.html
-7	/open-carburanti/provincia-tr/index.html/37329/6616/37330/52144/6617/54708/7547/56373/index.html
-8	/open-carburanti/provincia-tr/index.html/45183/4531/52144/6616/59699/9410/51533/54708/5707/index.html
-9	/open-carburanti/provincia-tr/index.html/42699/35734/24092/30409/9973/52796/60430/17814/54708/10091/index.html
-10	/open-carburanti/provincia-tr/index.html/42699/35734/24092/30409/19581/52225/4531/54708/9068/index.html

Opendata, web and dolomites

MISTRAL SIGNED

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

MISTRAL project word cloud

Explore the words cloud of the MISTRAL project. It provides you a very rough idea of what is the project "MISTRAL" about.

inform mistral purposes aging applicable ideal curated incorporated millions closer eastern disorders biomarker mitigate class cancer automate pandemic risk host complementary innovations continues infections antimicrobial immunotherapies datasets tool human antiretroviral full discoveries interventions outcomes cure clinical stratification acquiring chronic regions gut brings public deaths benefit expertise aids patient immunotherapy streamlining mechanistically resistance web software acquisition diseases despite health living hiv repository interpretations cloud made critical 60 world systemic stratify rationally immune unlock inflammation validate complications outcome 27 drug faced infection discover accessible microbiome accelerated successful resolved biomarkers soaring viral boost suggest team beings science impacts 2010 smes mankind designed irreversibly treatment therapeutic efficacy

Project "MISTRAL" data sheet

The following table provides information about the project.

Coordinator	FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA-CAIXA Organization address address: CARRETERA DE CANYET city: BARCELONA postcode: 8916 website: www.irsicaixa.es contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Spain [ES]
Total cost	9˙994˙383 €
EC max contribution	9˙994˙383 € (100%)
Programme	1. H2020-EU.3.1.3. (Treating and managing disease)
Code Call	H2020-SC1-2019-Two-Stage-RTD
Funding Scheme	RIA
Starting year	2020
Duration (year-month-day)	from 2020-01-01 to 2024-12-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA-CAIXA FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA-CAIXA Organization address address: CARRETERA DE CANYET city: BARCELONA postcode: 8916 website: www.irsicaixa.es contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (BARCELONA)	coordinator	3˙967˙500.00
2	KAROLINSKA INSTITUTET KAROLINSKA INSTITUTET Organization address address: Nobels Vag 5 city: STOCKHOLM postcode: 17177 website: www.ki.se contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	SE (STOCKHOLM)	participant	1˙490˙833.00
3	REGION HOVEDSTADEN REGION HOVEDSTADEN Organization address address: KONGENS VAENGE 2 city: HILLEROD postcode: 3400 website: www.regionh.dk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DK (HILLEROD)	participant	1˙017˙611.00
4	UNIVERSITE D'AIX MARSEILLE UNIVERSITE D'AIX MARSEILLE Organization address address: Boulevard Charles Livon 58 city: Marseille postcode: 13284 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (Marseille)	participant	730˙470.00
5	CASE WESTERN RESERVE UNIVERSITY CORPORATION CASE WESTERN RESERVE UNIVERSITY CORPORATION Organization address address: EUCLID AVENUE 10900 city: CLEVELAND OHIO postcode: 44106 7037 website: www.case.edu contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	US (CLEVELAND OHIO)	participant	727˙787.00
6	AELIX THERAPEUTICS SL AELIX THERAPEUTICS SL Organization address address: CALLE BALDIRI REIXAC, 4-8 city: BARCELONA postcode: 8028 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (BARCELONA)	participant	534˙978.00
7	FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA Organization address address: C ROSSELLO 132 PLANTA 05 city: BARCELONA postcode: 8036 website: www.isglobal.org contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (BARCELONA)	participant	448˙021.00
8	CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER Organization address address: CALLE ROSSELLO 149 PUERTA BJS city: BARCELONA postcode: 8036 website: http://www.idibaps.org/en_index.html contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (BARCELONA)	participant	351˙762.00
9	ASPHALION SL ASPHALION SL Organization address address: CALLE TARRAGONA, NUMEROS 151-157, PLANTA 10, BLOQU city: BARCELONA postcode: 8014 website: www.asphalion.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (BARCELONA)	participant	316˙187.00
10	PROJECTE DELS NOMS - HISPANOSIDA ASOCIACION PROJECTE DELS NOMS - HISPANOSIDA ASOCIACION Organization address address: COMTE BORRELL 164 166 BAIXOS city: BARCELONA postcode: 8015 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (BARCELONA)	participant	236˙737.00
11	VEDANTA BIOSCIENCES INC VEDANTA BIOSCIENCES INC Organization address address: CORPORATION TRUST CENTER 1209 ORANGE STREET city: WILMINGTON postcode: 19801 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	US (WILMINGTON)	participant	172˙493.00

Map

Project objective

The HIV/AIDS pandemic continues to be one of the major health challenges ever faced by mankind. Far from being resolved, HIV is soaring in Eastern Europe (60% increase in new infections and 27% increase in deaths since 2010) and other regions of the world despite increasing access to antiretroviral treatment. There is emerging evidence that the human microbiome impacts some of the most important clinical aspects of HIV-1 infection, including immune disorders, chronic inflammation and accelerated aging. Work in other viral diseases and cancer immunotherapy suggest a critical role of the human microbiome also in the outcome of immune therapeutic interventions in HIV-1 infection. The MISTRAL project brings together a team of world-class HIV and microbiome researchers and SMEs with ideal complementary knowledge and expertise. This team will work to discover and validate novel gut microbiome biomarkers to inform rationally-designed, mechanistically-driven interventions on the gut microbiome to mitigate HIV-1 acquisition, systemic inflammation, chronic clinical complications, antimicrobial drug resistance, and boost the efficacy of HIV cure immunotherapies. Integrated and curated large microbiome and host datasets generated during the execution of the project will be made public through a freely accessible, specifically-dedicated web-based repository. Biomarker discoveries will be incorporated into a cloud-based software tool that will automate microbiome analyses and interpretations, thus streamlining patient stratification for clinical and research purposes. If successful, MISTRAL will benefit millions of human beings living with, or at risk of acquiring HIV-1 infection, and will produce novel concepts and technical innovations applicable to other human diseases. By doing that, MISTRAL will help to unlock the full clinical potential of the human microbiome to stratify patient outcomes and will irreversibly bring microbiome science closer to clinical practice.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MISTRAL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MISTRAL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More

INADVANCE (2019)

Patient-centred pathways of early palliative care, supportive ecosystems and appraisal standard

Read More

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More